Market Size (2016)
2016
$15.30B
Healthcare
Tissue Engineering Market
By Segment, By Region, And Segment Forecasts, 2016 – 2024
Vertical: HealthcareBase Year: 201814 Sections
Executive Summary
Tissue Engineering Market — Snapshot
Projected (2024)
2024
$53.42B
CAGR (2016–2024)
16.9%
16.9%Key Players
109+
Tissue engineering mainly focuses on the development of tissue and organ substitutes by controlling biological parameters in the laboratory. It helps to elaborate the three-dimensional cellular constructs with properties more like natural tissues. Growing aging patient population, the rise in tissue engineering transplantations globally, and rising disease awareness drive the growth of the global tissue engineering market. However, stringent regulatory policies may hamper the growth of the market.
The global tissue engineering market is expected to register a CAGR of 17.84% during the forecast period from 2019 to 2024. In 2018, the market was led by the Americas with 39.3% share, followed by Europe and Asia-Pacific with shares of 30.4% and 21.4%, respectively.
The global tissue engineering market has been segmented based on material, application, and region.
Based on material, the nano-fibrous material segment accounted for the largest market share of 30.0% in 2018, with a market value of USD 6,117.81 million, which is projected to register a CAGR of 18.08% during the forecast period.
Based on application, the orthopedics, musculoskeletal and spine segment accounted for the largest market share of 33.4% in 2018, with a market value of USD 6,804.75 million, which is projected to register a CAGR of 17.03% during the forecast period.
Key Insight
The Tissue Engineering Market market is projected to grow at a CAGR of 16.9% from 2016 to 2024.
Market Performance Trend
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Scope & Coverage
What this report covers
- Geographic Coverage: This analysis covers 4 regions: Middle East and Africa, Americas, Asia Pacific, Europe.
- Market Segmentation: The market is analyzed across 5 segments: Nano-fibrous material, Biomimetic material, Composite material, Nano-composite material, Others. Forecasts are provided for each segment from 2016 to 2024.
- Competitive Landscape: 109 leading companies are profiled, covering market positioning, strategies, and recent developments.
Market Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Overview
Tissue Engineering Market — Growth Trajectory
Tissue engineering is designed to influence the physical, chemical, and biological environment surrounding the cell population. It is an interdisciplinary field that applies the principle of engineering and life science towards the development of biological products that help improve the functioning of tissues or a whole organ. Tissue engineering provides solutions that can replace or either repair tissue including transplant, surgical reconstruction, and medical devices. Moreover, increasing awareness regarding the benefit of tissue engineering in individuals as well as healthcare professionals would create more demand for these products. Hence it helps to boost the growth of the global tissue engineering market.
Tissue Engineering Market — Growth Trajectory
Nano-fibrous material
Biomimetic material
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size Trend (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Dimensions
How this market is segmented
- Material Material is broken down into: Nano-fibrous material, Biomimetic material, Composite material, Nano-composite material, Others.
- Application Application is broken down into: Orthopedics, Musculoskeletal and Spine, Cancer, Skin/Integumentary, Dental, Cardiology, Urology, Neurology, Cord Blood & Cell Banking, GI & Gynecology, Application_Others.
Geographic Analysis
Regional market breakdown
- Middle East and Africa Middle East and Africa market size reached $1.36B in 2016 and is projected to reach $4.83B by 2024, growing at a CAGR of 17.2%.
- Americas Americas market size reached $6.08B in 2016 and is projected to reach $20.29B by 2024, growing at a CAGR of 16.3%.
- Asia Pacific Asia Pacific market size reached $3.25B in 2016 and is projected to reach $11.79B by 2024, growing at a CAGR of 17.5%.
- Europe Europe market size reached $4.62B in 2016 and is projected to reach $16.51B by 2024, growing at a CAGR of 17.3%.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Methodology
Tissue Engineering Market — How We Researched This Market
This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2018
Historical Period
2016 – 2018
Forecast Period
2018 – 2024
Primary Interviews
150+
Research Process
Historical data (2016–2018) and forecast period (2018–2024)
1
Problem Definition
- Market scoping
- Objective setting
- Framework design
2
Secondary Research
- Literature review
- Data mining
- Trend analysis
3
Primary Research
- Expert interviews
- Field visits
- Surveys
4
Data Analysis
- Quantitative modeling
- Statistical testing
- Validation
5
Insights & Reporting
- Synthesis
- Recommendations
- Visualization
Research Depth
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Historical vs. Forecast Data
Historical (observed)
Forecast (modelled)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansCompetitive Landscape & Porter's Five Forces
Tissue Engineering Market — Competitive Analysis
Bargaining Power of Suppliers
The bargaining power of the suppliers estimates how easy it is for the suppliers to influence the prices of the tissue engineering market. The market impact of the supplier’s bargaining power is considered to have a medium level impact. Businesses must obtain the necessary resources that they need from the resource suppliers to carry out their activities. The price of tissue engineering products is determined by the interaction between the suppliers and the end users. The number of suppliers serving the tissue engineering market is high as compared to the number of tissue engineering manufacturing firms operating in the sector, while the competition among the suppliers is high due to the high value of the transaction. Thus, the firms have a strong position due to lower switching cost relative to the suppliers. The factors favoring the suppliers are the high degree of differentiation and high quality of inputs used in the manufacturing of tissue engineering products, which reduces the chances of a reliable and quality supplier being substituted.
Bargaining Power of Buyers
The bargaining power of the buyers assesses how easy it is for the buyers to affect the price of tissue engineering. The bargaining power of the buyer will be low for tissue engineering as the tolerance for substandard products and substitutes is less due to the critical role of the tissue engineering products. The tissue engineering market is a consolidated market with the buyers to firm concentration ratio being low which reduces the power of the buyers. The factors in favor of the buyer are, the rising availability of information to the buyers, increasing penetration of insurance, rising government incentives and reimbursements, and the rising price sensitivity of the buyers.
Threat of New Entrants
Threat from new entrants is low. The tissue engineering market is a specialized market with high growth potential and requiring high technological knowledge. The tissue engineering market is also highly sensitive to technological advancements and disruptive innovations. Development of any novel tissue engineering with even a small advantage over existing products will have a disastrous effect on the existing players. The tissue engineering industry has a high capital and research intensity which raises the bar for market entry with the capital investment in technology being very high. The tissue engineering market also needs highly skilled manpower. The research intensity and higher intellectual property utilized in the industry makes a new technology highly disruptive of existing technology and players.
Threat of Substitutes
The threat of substitutes is medium to high for the tissue engineering market. The threat from the substitutes arises when the customers or the buyers in the market can achieve the end-result using other means excluding the concerned market. Tissue engineering has poor alternatives in the form of synthetic implants. Synthetic implants and artificial products cannot challenge the application of tissue engineering either the huge future potential of tissue engineering. However, if the event of the development of any threat of a substitute it will affect the existing players to a high degree. Thus, product development of these alternatives possesses a significant risk to the tissue engineering market.
Intensity of Rivalry
Degree of competition is considered to have a high impact on the market. The intensity of competitive rivalry evaluates the capability and the level of rivalry among competitors in the market. It also refers to the extent to which firms within a market put pressure on one another and limit each other’s profit potential. Industries strive for a competitive advantage over their rivals, and the intensity or rivalry varies across industries. Rivalry among market players can affect market profits through downward pressure on prices, increased innovation, increased advertising, and increased service/product improvements, among others. So, the intensity of rivalry is high.
Quantitative Analysis
Regional Breakdown
Regional market breakdown for Tissue Engineering Market.
Regional Market Size (USD Mn)
Market estimates by geography (2024)
USD Mn
InsightAmericas leads with $20.29B by 2024, while Asia Pacific is projected to grow fastest at a 17.5% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansRegional Market Data
| REGION | 2016 | 2018 | 2024 | CAGR | SHARE |
|---|---|---|---|---|---|
| Middle East and Africa | $1.36B | $2.47B | $4.83B | 17.2% | 9% |
| Americas | $6.08B | $10.70B | $20.29B | 16.3% | 38% |
| Asia Pacific | $3.25B | $5.96B | $11.79B | 17.5% | 22% |
| Europe | $4.62B | $8.42B | $16.51B | 17.3% | 31% |
| Total | $15.30B | $27.56B | $53.42B | 16.9% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSegment Revenue (2024)
Nano-fibrous material
Biomimetic material
Composite material
Nano-composite material
Others
0446589301339417859
Segment Market Share
- Nano-fibrous material30%
- Biomimetic material23%
- Composite material20%
- Nano-composite material18%
- Others8%
Total Market Size
$53.42B
Market by Segment (2024)
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Nano-fibrous material | $16.24B | 16.9% | 81% |
| Biomimetic material | $12.54B | 16.9% | 47% |
| Composite material | $10.86B | 16.9% | 77% |
| Nano-composite material | $9.56B | 16.9% | 82% |
| Others | $4.24B | 16.9% | 53% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansEmpower your Business
with InsightsSave over 20% on
with Insights
Save over 20% on
Annual Subscription
See plans for professionals or small and medium businesses.
Analytics
Tissue Engineering Market — Key Findings
Analytical insights on Tissue Engineering Market covering market dynamics, competitive landscape, and strategic outlook.
Key Analytical Findings
The Tissue Engineering Market market is projected to reach $53.42B by 2024, growing at 16.9% CAGR. The Nano-fibrous material segment holds the largest share.
Market Dynamics
Tissue engineering provides solutions that can replace tissue repair solutions that are currently used. These tissue repair solutions include transplants, surgical reconstruction, and mechanical devices. The growing geriatric population, increasing incidence rate of chronic and infectious diseases, 3D bioprinting emerging as a novel tissue engineering strategy due to its cost efficiency, and increased focus of companies on tissue engineering-based therapies are the factors that are enhancing the market growth of the segment. However, lack of awareness regarding tissue engineering, lack of skilled professionals, and stringent regulatory policies are projected to curb the growth of the market.
Market Drivers
Geriatric population, i.e., people above the age of 65 years have low immunity and are more vulnerable towards suffering from various types of disorders. Additionally, along with the lower immune response, aged people are more prone to suffer from chronic wounds as compared to young people. Moreover, they have high chances of transplant rejection. Therefore, cell transplantation, which is a branch of tissue engineering is a prominent solution to tackle such problems. According to the Office for National Statistics in 2017, approximately 18% and 2.4% of the total UK population was aged over 65 years and 85 years, respectively. Hence, increasing geriatric population is positively impacting the growth of the global tissue engineering market.
Market Opportunities
Developing economies pose an opportunity for various markets as they have undeveloped research and development sectors owing to which they are unable to address upcoming health challenges. Despite huge demand, the African region is dependent on imported medicines and other health technologies. Although there is a high requirement for treatment, poor economic conditions lead to the slow growth of the healthcare industry within the African region. As per the statistics of the National Centre for Biotechnology Information (NCBI) in 2016, around 180 patients from West China Hospital who underwent excision of skin lesions, treated with cell therapy lived in low- and middle-income countries. This huge population affected with the chronic diseases in developing countries serves as a strong opportunity for key players operating in the tissue engineering market.
Market Restraints
Although tissue engineering is an emerging field, there is low awareness about the technology among healthcare professionals in emerging economies. While there is a huge scope for tissue engineering in the healthcare industry, the practical implementation of its applications is yet to be derived. Additionally, in case of 3D bioprinting technology of tissue engineering, 3D printers on a commercial scale are still to be developed on a large scale due to expensive nature of bioprinter, lack of awareness, and scalability of machines. Therefore, the lack of awareness regarding tissue engineering and its applications inhibit market growth in emerging economies.
Strategic Outlook and Future Directions
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Market Value by Segment (2024)
Value (USD Mn)
Nano-fibrous material
Biomimetic material
Composite material
Nano-composite material
Others
Companies
Key companies profiled in Tissue Engineering Market
Profiles of 109 companies operating in the Tissue Engineering Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
Acelity
Acelity
Healthcare
Company Headquarters: San Antonio, Texas, US Founded: 1976 Workforce: 5,000+ Company Working: Acelity is a major market player in manufacturing and providing healthcare solutions related to the wound management. The company is into wound management, open abdomen management, incision management, epidermal harvesting, and animal health. Acelity is present in all major and emerging markets which include more than 90 countries. It concentrates on providing quality products and improving people’s health. The presence of Acelity in the global market is noticeable, and the company holds a significant market share.
RevenueN/A
Employees5,000
Market CapN/A
Founded1975
San Antonio, Texas, US
Organovo H
Organovo Holdings Inc.
Healthcare
Company Headquarters: San Diego, US Founded: 2007 Workforce: 115+ Company Working: Organovo Holdings Inc. is a leading biotechnology company which provides 3D bioprinting functional tissues. The company focuses on manufacturing three-dimensional tissues, and these tissues are used in various research and development activities as well as in implant therapies. Moreover, it depends on collaborations and strategic agreements with biopharmaceutical companies, research institutes, and healthcare providers to expand its business. Organovo Holdings Inc. provides products and services related to therapeutic tissues, high-quality human cells (samsara), and disease modeling platform that supports drug discovery and development.
Revenue$0.0B
Employees115
Market CapN/A
Founded2006
San Diego, US
Baxter Int
Baxter International
Healthcare
Company Headquarters: Deerfield, Illinois, US Founded: 1931 Workforce: ~50,000 Company Working: Baxter International Inc. (Baxter) is a Fortune 500 American health care company with headquarters in Deerfield, Illinois, US. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders, and other chronic and acute medical conditions. Baxter is a leading producer of intravenous (IV) fluids and systems. It also manufactures infusion pumps, pre-filled syringes, biological sealants, and inhaled anesthetics, as well as dialyzers and other products for the treatment of end-stage renal disease. Its global footprint and critical nature of products and services play a key role in expanding access to healthcare in emerging and developed countries. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and patients at home under physician supervision. As of December 31, 2018, Baxter manufactured products in over 20 countries and sold them in over 100 countries.
Revenue$10.2B
Employees50,000
Market CapN/A
Founded1930
Deerfield, Illinois, US
Allergan
Allergan
Healthcare
Company Headquarters: Dublin, Ireland Founded: 2013 Workforce: ~16,900 Company Working: Allergan is a leading global pharmaceutical company. The company is engaged in the manufacturing and commercialization of hyaluronic acid for medical products, devices, biologics, and surgical products for patients across the world. It operates through three business segments, namely US Specialized Therapeutics, US General Medicine, and International. The company sells its products primarily to the retailers and distributors including food store chains and national retail drug. The prime customers are hospitals, clinics, and government agencies as well as managed healthcare providers, such as health maintenance organizations and other institutions. The company has operations in 100 countries. The US and Canada account for around 10% of the company’s revenue. The three prominent customers of the company are McKesson Corporation, which accounted for around 25% of the sales revenue; Cardinal Health, Inc with 23%; and AmerisourceBergen Corporation with 22% in 2018. In addition, the company has development and manufacturing centers of raw materials, intermediate ingredients, and active pharmaceutical ingredients. Its manufacturing plants are located in Ireland, the US, Brazil, Belgium, France, and Costa Rica.
Revenue$14.6B
Employees16,900
Market CapN/A
Founded2012
Dublin, Ireland
Zimmer Bio
Zimmer Biomet
Healthcare
Company Headquarters: Warsaw, Indiana, (US) Founded: 1927 Workforce: 19,000+ Company Working: Zimmer develops, produces, and markets musculoskeletal healthcare products. It is a leading brand in providing customized joint and bone healthcare solutions. It offers products related to orthopedics, healthcare, medical instruments, medical technology, surgical instruments, medical supplies, medical devices, innovation, and signature solutions. The company is present in all major markets and holds significant market share in the global tissue engineering market.
Revenue$7.7B
Employees19,000
Market CapN/A
Founded1926
Warsaw, Indiana, (US)
Integra Li
Integra LifeSciences Corporation
Healthcare
Company Headquarters: New Jersey, US Founded: 1989 Workforce: ~4,500 Company Working: Integra LifeSciences Holdings Corporation (Integra) is a world leader in medical technology. It offers innovative solutions for orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive & general surgery. Integra offers a broad portfolio of brands that include AmnioExcel, Bactiseal, Cadence, Certas, Codman, CUSA, DuraGen, DuraSeal, ICP Express, Integra, MediHoney, MicroFrance, PriMatrix, Salto Talaris, SurgiMend, TCC-EZ, Titan, and VersaTru. It sells its products through two business segments, namely, Codman specialty surgical and orthopedics and tissue technologies. It recently acquired one of the leading players of the global amniotic membrane market, Derma Sciences Inc. (US), a tissue regeneration company. Integra provides its innovative healthcare solutions in over 130 countries through more than 50 offices and worldwide distribution networks.
Revenue$1.0B
Employees4,500
Market CapN/A
Founded1988
New Jersey, US
Page 1 of 19
…
Go to page
Powering the world's best teams.
From next-gen startups to established enterprises.
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Tissue Engineering Market
Starting from
$4,950